BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 29985834)

  • 21. Evaluating the Thyroid Eye Disease Patient.
    Denisova K; Barmettler A
    Int Ophthalmol Clin; 2021 Apr; 61(2):33-52. PubMed ID: 33743527
    [No Abstract]   [Full Text] [Related]  

  • 22. Compressive Optic Neuropathy in Thyroid Eye Disease.
    Thyparampil P; Yen MT
    Int Ophthalmol Clin; 2016; 56(1):51-67. PubMed ID: 26626932
    [No Abstract]   [Full Text] [Related]  

  • 23. Strabismus associated with thyroid eye disease.
    Schotthoefer EO; Wallace DK
    Curr Opin Ophthalmol; 2007 Sep; 18(5):361-5. PubMed ID: 17700227
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Graves' ophthalmopathy].
    Eckstein A; Dekowski D; Führer-Sakel D; Berchner-Pfannschmidt U; Esser J
    Ophthalmologe; 2016 Apr; 113(4):349-64; quiz 465-6. PubMed ID: 27059986
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical perspectives of thyroid eye disease.
    Durairaj VD
    Am J Med; 2006 Dec; 119(12):1027-8. PubMed ID: 17145242
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Consensus statement of the European Group on Graves' orbitopathy (EUGOGO) on management of GO.
    Bartalena L; Baldeschi L; Dickinson A; Eckstein A; Kendall-Taylor P; Marcocci C; Mourits M; Perros P; Boboridis K; Boschi A; Currò N; Daumerie C; Kahaly GJ; Krassas GE; Lane CM; Lazarus JH; Marinò M; Nardi M; Neoh C; Orgiazzi J; Pearce S; Pinchera A; Pitz S; Salvi M; Sivelli P; Stahl M; von Arx G; Wiersinga WM;
    Eur J Endocrinol; 2008 Mar; 158(3):273-85. PubMed ID: 18299459
    [No Abstract]   [Full Text] [Related]  

  • 27. Commentary: Multidisciplinary team approach to tackle thyroid eye disease.
    Mahesh L
    Indian J Ophthalmol; 2020 Aug; 68(8):1615-1616. PubMed ID: 32709790
    [No Abstract]   [Full Text] [Related]  

  • 28. Management of thyroid eye disease in the United Kingdom: A multi-centre thyroid eye disease audit.
    Mellington FE; Dayan CM; Dickinson AJ; Hickey JL; MacEwen CJ; McLaren J; Perros P; Rose GE; Uddin J; Vaidya B; Foley P; Lazarus JH; Mitchell A; Ezra DG;
    Orbit; 2017 Jun; 36(3):159-169. PubMed ID: 28296512
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Management of Graves' orbitopathy. Comments on the EUGOGO consensus statement].
    Bednarczuk T; Bar-Andziak E; Hubalewska-Dydejczyk A; Waligórska A; Górska M; Myśliwiec J; Jarzab B; Karczmarzyk R; Zawadzka A; Garmol D; Kecik D; Królicki L; Plazińska MT; Krzeski A; Krzyzanowska-Swiniarska B; Lewiński A; Milewicz A; Daroszewski J; Placzkiewicz-Jankowska E; Pilarska K; Skórski M; Wiechno W; Sowiński J; Syrenicz A; Szafilk J; Wanyura H; Zgliczński W; Jastrzebska H; Nauman J
    Endokrynol Pol; 2009; 60(4):312-30. PubMed ID: 19753546
    [No Abstract]   [Full Text] [Related]  

  • 30. Optimal management of Graves orbitopathy: a multidisciplinary approach.
    Soeters MR; van Zeijl CJ; Boelen A; Kloos R; Saeed P; Vriesendorp TM; Mourits MP
    Neth J Med; 2011; 69(7):302-8. PubMed ID: 21934174
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical practice. Graves' ophthalmopathy.
    Bartalena L; Tanda ML
    N Engl J Med; 2009 Mar; 360(10):994-1001. PubMed ID: 19264688
    [No Abstract]   [Full Text] [Related]  

  • 32. Thyroid eye disease for the primary care physician.
    Phelps PO; Williams K
    Dis Mon; 2014 Jun; 60(6):292-8. PubMed ID: 24906675
    [No Abstract]   [Full Text] [Related]  

  • 33. The diagnosis and treatment of thyroid-associated ophthalmopathy.
    Gould DJ; Roth FS; Soparkar CN
    Aesthetic Plast Surg; 2012 Jun; 36(3):638-48. PubMed ID: 22083413
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Worldwide Consensus on Thyroid Eye Disease? What Is In a Name?
    Wiersinga WM
    Thyroid; 2022 Dec; 32(12):1431-1433. PubMed ID: 36480278
    [No Abstract]   [Full Text] [Related]  

  • 35. Thyroid Eye Disease: A New Name, A New Guide, and A New Era.
    Davies TF
    Thyroid; 2022 Dec; 32(12):1434-1436. PubMed ID: 36480286
    [No Abstract]   [Full Text] [Related]  

  • 36. Quality of life in thyroid eye disease: impact of quality of care.
    Estcourt S; Quinn AG; Vaidya B
    Eur J Endocrinol; 2011 May; 164(5):649-55. PubMed ID: 21367964
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Viral conjunctivitis interfering with the clinical activity score and management of thyroid ophthalmopathy.
    Boboridis KG; Konstas AG; Krassas GE; Georgiadis NS
    Orbit; 2006 Mar; 25(1):27-9. PubMed ID: 16527772
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Basedow's ophthalmopathy].
    Raynaud L; Benois A; Lafond P
    Rev Prat; 2008 May; 58(10):1060. PubMed ID: 18652402
    [No Abstract]   [Full Text] [Related]  

  • 39. [Current management of endocrine orbitopathy].
    Ponto KA; Kahaly GJ
    Med Klin (Munich); 2008 Oct; 103(10):717-30; quiz 729-30. PubMed ID: 18936897
    [No Abstract]   [Full Text] [Related]  

  • 40. Orbital lymphoma associated with Graves' disease: A case report.
    Hajduković Z; Kuzmić-Janković S; Kljaković-Avramović T; Sekulović L; Tukić L
    Vojnosanit Pregl; 2014 May; 71(5):510-4. PubMed ID: 26137719
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.